Clinical Usefulness of Diquafosol for Real-World Dry Eye Patients: A Prospective, Open-Label, Non-Interventional, Observational Study

Yamaguchi M., Nishijima T., Shimazaki J., Takamura E., Yokoi N., Watanabe H., Ohashi Y.

2014
Advances in Therapy

View publication

Therapeutic Area

Front of the eye (FOTE)
Categories

Clinical development

Affiliations

Ehime University School of Medicine, Ehime, Japan; Santen Pharmaceutical Co., Ltd, Osaka, Japan; Tokyo Dental College Ichikawa General Hospital, Chiba, Japan; Tokyo Women’s Medical University, School of Medicine, Tokyo, Japan; Kyoto Prefectural University of Medicine, Kyoto, Japan; Kansai Rosai Hospital, Hyogo, Japan

Related Publications

Six-month efficacy and safety of oxymetazoline hydrochloride 0.1% in Japanese patients with acquired blepharoptosis: a phase 3 study

Ishikawa H., Oka K., Inoue H.

Tear Biomarkers of Topical Sirolimus in Meibomian Gland Dysfunction: A Randomized Trial

Zhou L.; Shimizu H.; Togashi Y.; Kirihara T.; Yang Y.; Lam C.T.; Shimada H.; Tong L.

Layer-by-layer tear film measurement in patients with dry eye and meibomian gland dysfunction

Arita R., Takeuchi G., Sasai K., Nakamura M., Akiba M.

View all Front of the eye (FOTE) publications

Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022